Patients with AD and brains from APP transgenic animals display increased levels of inflammatory cytokines and chemokines, including interferon γ (IFNγ), tumor necrosis factor α (TNFα), interleukin 1β (IL-1β), and interleukin 6 (IL-6) [7]. Here, TNF is linked to Alzheimer disease.